Roundview Capital LLC Trims Position in UnitedHealth Group Incorporated (NYSE:UNH)

Roundview Capital LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 23,439 shares of the healthcare conglomerate's stock after selling 1,240 shares during the quarter. UnitedHealth Group makes up 0.8% of Roundview Capital LLC's holdings, making the stock its 25th largest holding. Roundview Capital LLC's holdings in UnitedHealth Group were worth $11,857,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of UNH. NewSquare Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter worth $25,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $30,000. Promus Capital LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at about $32,000. Pillar Financial Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter worth approximately $40,000. Finally, DecisionPoint Financial LLC raised its holdings in UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock valued at $52,000 after buying an additional 62 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Up 0.1 %

UNH stock traded up $0.49 during midday trading on Wednesday, hitting $523.61. 2,368,702 shares of the company's stock were exchanged, compared to its average volume of 4,265,457. The business has a 50-day simple moving average of $509.06 and a two-hundred day simple moving average of $542.96. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The stock has a market capitalization of $478.95 billion, a PE ratio of 33.78, a P/E/G ratio of 1.37 and a beta of 0.62.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. During the same period last year, the firm earned $5.83 earnings per share. The company's revenue for the quarter was up 6.8% compared to the same quarter last year. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 54.19%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on UNH. Barclays reduced their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research note on Friday, January 17th. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Truist Financial reduced their price target on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research note on Tuesday, December 3rd. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.